MSTN and Insulin resistance: Furthermore, dysregulation of myokines in SO patients—characterized by diminished secretion of irisin and FGF21 or heightened secretion of myostatin (MSTN)—can exacerbate insulin resistance, diminish antioxidant capacity, accelerate LDL oxidation, and provoke the release of proinflammatory factors from adipose tissue.